HomeITRM • NASDAQ
add
Iterum Therapeutics PLC
Previous close
$0.95
Day range
$0.95 - $0.98
Year range
$0.81 - $3.02
Market cap
38.80M USD
Avg Volume
561.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.37M | -45.35% |
Net income | -4.89M | 31.12% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.36M | 45.40% |
Effective tax rate | -1.24% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.65M | -30.54% |
Total assets | 32.98M | 68.03% |
Total liabilities | 35.53M | 37.84% |
Total equity | -2.55M | — |
Shares outstanding | 40.00M | — |
Price to book | -13.57 | — |
Return on assets | -23.91% | — |
Return on capital | -26.12% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.89M | 31.12% |
Cash from operations | -3.06M | 76.61% |
Cash from investing | -2.00K | -100.03% |
Cash from financing | -8.39M | -216.23% |
Net change in cash | -11.47M | -970.49% |
Free cash flow | -1.94M | 81.93% |
About
Founded
2015
Website
Employees
9
